Prolotherapy for Musculoskeletal Pain and Disability in Low- and Middle-Income Countries

David Rabago, Kenneth Dean Reeves, Mary P. Doherty, Maelu Fleck

Research output: Contribution to journalReview article

Abstract

Chronic musculoskeletal pain and disability dramatically reduce quality and quantity of life worldwide, disproportionately so in low- and middle-income countries. Complementary therapies not typically learned in conventional medical training have much to offer but are under-utilized. Prolotherapy is an injection-based complementary therapy supported by high-quality evidence for osteoarthritis, tendinopathy, and low back pain. Prolotherapy addresses causes of pain and disability at the tissue level, is straightforward to learn, and relies on common, inexpensive material, and requires no refrigeration. Not-for-profit organizations are delivering prolotherapy to underserved patients in low- and middle-income countries through service-learning projects.

Original languageEnglish (US)
Pages (from-to)775-786
Number of pages12
JournalPhysical Medicine and Rehabilitation Clinics of North America
Volume30
Issue number4
DOIs
StatePublished - Nov 2019

All Science Journal Classification (ASJC) codes

  • Physical Therapy, Sports Therapy and Rehabilitation
  • Rehabilitation

Fingerprint Dive into the research topics of 'Prolotherapy for Musculoskeletal Pain and Disability in Low- and Middle-Income Countries'. Together they form a unique fingerprint.

  • Cite this